CARAMORI, Gaetano
 Distribuzione geografica
Continente #
NA - Nord America 3.710
EU - Europa 2.661
AS - Asia 1.192
OC - Oceania 4
Totale 7.567
Nazione #
US - Stati Uniti d'America 3.704
IE - Irlanda 1.421
CN - Cina 1.109
SE - Svezia 575
IT - Italia 434
PL - Polonia 92
DE - Germania 56
IN - India 50
BE - Belgio 17
GB - Regno Unito 16
VN - Vietnam 14
FI - Finlandia 13
FR - Francia 11
RU - Federazione Russa 8
AT - Austria 7
CA - Canada 6
AU - Australia 4
NL - Olanda 4
TR - Turchia 3
TW - Taiwan 3
UA - Ucraina 3
BG - Bulgaria 2
IR - Iran 2
JP - Giappone 2
KR - Corea 2
MY - Malesia 2
PH - Filippine 2
GR - Grecia 1
ID - Indonesia 1
IQ - Iraq 1
RO - Romania 1
TH - Thailandia 1
Totale 7.567
Città #
Dublin 1.421
Chandler 541
Dearborn 509
Nyköping 399
Princeton 327
Beijing 309
Jacksonville 266
Des Moines 232
San Mateo 224
Cambridge 219
Ashburn 184
Messina 169
Medford 168
Jinan 116
Shenyang 109
Warsaw 92
Nanjing 61
Wilmington 59
Ningbo 57
Tianjin 57
Zhengzhou 50
Ann Arbor 48
Hebei 47
Bremen 46
Haikou 39
Lanzhou 38
Nanchang 38
Pune 37
Hangzhou 31
Taizhou 28
Rome 21
New York 20
Fuzhou 19
Guangzhou 18
Brussels 17
Jiaxing 17
Changsha 15
Naples 15
Cassino 14
Dong Ket 14
Milan 13
Norwalk 13
Seattle 12
Falls Church 11
Saint Petersburg 7
Hyderabad 6
Boardman 5
Lancaster 5
Mountain View 5
New Delhi 5
Ottawa 5
Taiyuan 5
Vienna 5
Fairfield 4
Hefei 4
Houston 4
Kunming 4
Lappeenranta 4
Los Angeles 4
Mineo 4
Padova 4
Redmond 4
San Giuliano Terme 4
The Bronx 4
Washington 4
Aci Bonaccorsi 3
Adelaide 3
Birmingham 3
Brescia 3
Cagliari 3
Canicattì 3
Capannori 3
Castenaso 3
Cossato 3
Florence 3
Grandate 3
Helsinki 3
Iowa City 3
Lesignano de' Bagni 3
Piazza Armerina 3
Redwood City 3
Speyer 3
Turin 3
Wuhan 3
Ancona 2
Aragona 2
Bologna 2
Brooklyn 2
Catania 2
Fort Worth 2
Glasgow 2
Graz 2
Legnano 2
London 2
Melton Mowbray 2
Montreuil 2
Mori 2
Motta Sant'Anastasia 2
Paterno 2
Peschiera 2
Totale 6.325
Nome #
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 129
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD 85
Molecular links between COPD and lung cancer: new targets for drug discovery? 79
Hereditary hyperhomocysteinemia associated with nephrotic syndrome complicated by artery thrombosis and chronic thromboembolic pulmonary hypertension: A case report 69
Polmonite interstiziale fibrosante da amiodarone 68
Functional role of inflammasome activation in a subset of obese nonsmoking patients with severe asthma 64
Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression. 63
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 62
Role of Stem Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Pulmonary Emphysema 62
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD 62
Asthma under/misdiagnosis in primary care setting: An observational community-based study in Italy 61
Autoimmunity and COPD: Clinical Implications 56
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis 52
Role of Atypical Chemokines and Chemokine Receptors Pathways In the Pathogenesis of COPD 51
2 agonisti inalatori nel trattamento dell’asma bronchiale e delle broncopneumopatie croniche ostruttive. 50
An unusual cause of chest pain 50
Bacterial infections in the lungs of patients with systemic autoimmune diseases 50
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 49
Controllo della broncopneumopatia cronica ostruttiva in Italia 49
Trattamento personalizzato dei pazienti con BPCO in fase stabile [Personalised treatment of stable COPD patients] 48
Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine 48
Posttranscriptional Gene Regulatory Networks in Chronic Airway Inflammatory Diseases: In silico Mapping of RNA-Binding Protein Expression in Airway Epithelium 48
AN UNUSUAL CASE OF CHRONIC AIRFLOW OBSTRUCTION IN A HEAVY SMOKER 48
Allergen Responses Modified by a GATA3 DNAzyme 47
Role of the mucins in pathogenesis of COPD: implications for therapy 47
Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype? 46
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines 46
Attuali progressi nel trattamento dell’asma bronchiale nell’adulto. 45
Asma. 45
Transcription inhibitors and inflammatory cell activity 45
Differential diagnosis between newly diagnosed asthma and chronic obstructive pulmonary disease using exhaled breath condensate metabolomics: a pilot study 45
OXIDANTS AND ANTIOXIDANTS | Antioxidants, Nonenzymatic 45
Rischio di polmonite durante trattamenti regolari a lungo termine con glucocorticoidi inalatori nei pazienti con BPCO stabile: Revisione sistematica della letteratura 44
Activation of NF-kappaB transcription factor in asthma death 44
Anatomia e fisiologia clinica della pleura. 43
D-dimer value in the diagnosis of pulmonary embolism — May it exclude only? 43
Ultrasound assessment of diaphragm function in patients with late-onset Pompe disease 43
Anti-inflammatory mechanisms of glucocorticoids targeting granulocytes. 42
Asma. 42
Asthma death. 42
The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide 42
Commentary on "Major Complications Associated with Conventional Transbronchial Needle Aspiration" 42
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. 41
Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease 40
Airway obstruction in chronic obstructive pulmonary disease. 39
Interferonopathy: A potential link between innate immunity and autoimmunity in the pathogenesis of COPD 39
Anti-inflammatory treatments for asthma: past, present, future. 38
Asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study. 38
Asthma: a chronic infectious disease? 38
A case of fibrosing interstitial pneumonia 38
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 37
Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD 37
New drugs under development for COPD 37
Gender differences in COPD management in a Sicilian general practice setting: a cohort study evaluating the impact of educational interventions 37
Corticosteroid resistance in asthma: Cellular and molecular mechanisms 37
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease 35
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 35
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper 35
Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease 35
FN3K expression in COPD: A potential comorbidity factor for cardiovascular disease 35
[Risk of diabetes mellitus during regular long-term inhaled glucocorticoid treatment in COPD patients: narrative review of the literature.] 35
Epithelial Posttranscriptional Gene Regulatory Networks In Chronic Airway Inflammation: In Silico Mapping Of RNA-Binding Protein Expression 34
Malattie virali dell’apparato respiratorio 34
Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature 34
Evaluation of Innate Immune Mediators Related to Respiratory Viruses in the Lung of Stable COPD Patients 34
An unusual cause of dyspnoea in a patient with chronic ischemic heart disease 34
COPD immunopathology 33
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients 33
Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients 33
Sport e inquinamento atmosferico 32
Stato dell’arte degli antileucotrienici nella terapia dell’asma. 32
Polmoniti da parassiti 32
Birbeck granules: contribution to the comprehension of intracytoplasmic evolution. 32
A case of lung injury resembling diffuse pulmonary hemorrhage after the first administration of alemtuzumab in a patient with multiple sclerosis. Role of the HRCT 32
Methotrexate in the treatment of systemic glucocorticoid dependent severe persistent astma: a word of caution. 31
Targeting Th2 cells in asthmatic airways 30
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 30
La teofillina nella BPCO: nuove prospettive (3° parte). 29
Gli antagonisti dei leucotrieni: nuove speranze nella terapia dell'asma? 29
Oxidative Stress-induced Antibodies to Carbonyl-modified Protein Correlate with Severity of Chronic Obstructive Pulmonary Disease 29
Studio clinico-epidemiologico sulle neoplasie polmonari maligne. Confronto tra 2 coorti di pazienti nei quinquenni 1981-5 e 1991-5. 29
A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. 29
Breaking news: DNA damage and repair pathways in COPD and implications for pathogenesis and treatment 29
null 29
Versamento ed empiema pleurico parapneumonico nell’adulto 29
A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis 29
Treatable traits in COPD patients 28
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 28
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 28
La scoperta dell’ossido nitrico endogeno ha aperto nuove prospettive terapeutiche nella patologia polmonare dell’adulto? 28
Teofillina: effetti polmonari ed extrapolmonari nei pazienti con asma e BPCO; nuove prospettive. 27
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease. 27
Donna non fumatrice con asma bronchiale difficile da controllare. 27
Pulmonary vasculitis: classification, clinical features and management. 27
Broncodilatatori nella terapia delle broncopneumopatie croniche ostruttive. 26
Morte per asma. Parte I: fenotipi clinici, epidemiologia e fattori di rischio. 26
Le linee guida vengono seguite? 26
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 26
Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs 26
Delivery systems e protocollo di Montreal. 26
Totale 4.104
Categoria #
all - tutte 43.633
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.633


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 0 0 7
2019/2020924 7 0 5 3 3 443 112 26 34 191 85 15
2020/20211.371 19 19 710 21 277 8 14 91 83 59 44 26
2021/20221.672 5 65 5 273 27 13 181 87 21 73 336 586
2022/20232.907 368 189 104 152 134 184 35 96 1.557 8 52 28
2023/2024619 53 81 54 86 71 170 24 31 5 27 11 6
Totale 8.081